We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Bristol Myers Squibb Co | NYSE:BMY | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.18 | 0.40% | 44.88 | 45.37 | 44.34 | 44.73 | 21,281,928 | 01:00:00 |
From Apr 2019 to Apr 2024
The FDA approved Empliciti to be used in combination with two other FDA-approved treatments, dexamethasone and Revlimid. "FDA Approves New Blood-Cancer Drug Empliciti," published at 11:38 a.m. ET, and an update, incorrectly said Darzalex was used in this drug cocktail.
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
(END) Dow Jones Newswires
November 30, 2015 12:41 ET (17:41 GMT)
Copyright (c) 2015 Dow Jones & Company, Inc.
1 Year Bristol Myers Squibb Chart |
1 Month Bristol Myers Squibb Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
